DK120949B - Analogifremgangsmåde til fremstilling af ethere af 3-oxygenerede-13β-alkyl-17β-hydroxygona-4,9,11-triener. - Google Patents

Analogifremgangsmåde til fremstilling af ethere af 3-oxygenerede-13β-alkyl-17β-hydroxygona-4,9,11-triener.

Info

Publication number
DK120949B
DK120949B DK168367A DK168367A DK120949B DK 120949 B DK120949 B DK 120949B DK 168367 A DK168367 A DK 168367A DK 168367 A DK168367 A DK 168367A DK 120949 B DK120949 B DK 120949B
Authority
DK
Denmark
Prior art keywords
hydroxygona
trienes
oxygenated
ethers
alkyl
Prior art date
Application number
DK168367A
Other languages
Danish (da)
English (en)
Inventor
L Nedelec
J Gasc
R Bucourt
J Dube
J Tessier
G Costerousse
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK120949B publication Critical patent/DK120949B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK168367A 1966-01-21 1967-03-30 Analogifremgangsmåde til fremstilling af ethere af 3-oxygenerede-13β-alkyl-17β-hydroxygona-4,9,11-triener. DK120949B (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
FR46778 1966-01-21
FR56491A FR5301M (xx) 1966-01-21 1966-04-05
FR58471A FR5320M (xx) 1966-01-21 1966-04-21
FR61569A FR5484M (xx) 1966-01-21 1966-05-13
FR68757A FR1492985A (fr) 1966-01-21 1966-07-08 éthers-oxydes de stéroïdes insaturés et procédés de préparation
FR85819A FR6425M (xx) 1966-01-21 1966-12-01
FR95053A FR6096M (xx) 1966-01-21 1967-02-15

Publications (1)

Publication Number Publication Date
DK120949B true DK120949B (da) 1971-08-09

Family

ID=27562279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK168367A DK120949B (da) 1966-01-21 1967-03-30 Analogifremgangsmåde til fremstilling af ethere af 3-oxygenerede-13β-alkyl-17β-hydroxygona-4,9,11-triener.

Country Status (10)

Country Link
AT (1) AT280493B (xx)
BE (1) BE696084A (xx)
CH (1) CH474499A (xx)
DK (1) DK120949B (xx)
ES (5) ES338882A1 (xx)
FR (6) FR5301M (xx)
GB (1) GB1175456A (xx)
IL (1) IL27745A (xx)
NL (1) NL6704829A (xx)
SE (1) SE320364B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183555B1 (xx) * 1972-05-10 1975-06-20 Roussel Uclaf
FR2285138A1 (fr) * 1974-09-20 1976-04-16 Roussel Uclaf Nouveau derive steroide trienique, son procede de preparation et son application comme medicament
FR2388560A1 (fr) * 1977-04-27 1978-11-24 Roussel Uclaf Nouvelles compositions zootechniques renfermant d'une part le zeranol et d'autre part un steroide 4,9,11 trienique

Also Published As

Publication number Publication date
CH474499A (fr) 1969-06-30
GB1175456A (en) 1969-12-23
FR5484M (xx) 1967-10-23
ES347368A1 (es) 1969-02-01
FR1492985A (fr) 1967-08-25
ES340433A1 (es) 1968-06-01
NL6704829A (xx) 1967-10-06
ES342740A1 (es) 1968-08-01
FR5320M (xx) 1967-08-21
BE696084A (xx) 1967-09-25
FR5301M (xx) 1967-08-16
SE320364B (xx) 1970-02-09
FR6096M (xx) 1968-06-10
ES350471A2 (es) 1969-05-01
ES338882A1 (es) 1968-04-16
FR6425M (xx) 1968-11-04
IL27745A (en) 1974-10-22
AT280493B (de) 1970-04-10

Similar Documents

Publication Publication Date Title
DK121857B (da) Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater.
DK120546B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK112726B (da) Fremgangsmåde til fremstilling af 1,6-dibrom-1,6-didesoxydulcitol.
DK114767B (da) Analogifremgangsmåde til fremstilling af 1,1-diphenyl-2-methyl-3-(benzylidenamino)propanoler.
DK116656B (da) Analogifremgangsmåde til fremstilling af 11-oxygenerede 3-(2'-chlorethylthio)-6-formyl-9α-fluor-3,5-pregnadien-20-oner.
DK115617B (da) Fremgangsmåde til fremstilling af 2,2-dichlor-1,1,3,3-tetrafluorpropan.
DK120949B (da) Analogifremgangsmåde til fremstilling af ethere af 3-oxygenerede-13β-alkyl-17β-hydroxygona-4,9,11-triener.
DK114556B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK123169B (da) Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK118406B (da) Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler.
DK126105B (da) Fremgangsmåde til fremstilling af meget ren 2,6-xylenol.
DK116594B (da) Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK117955B (da) Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.
DK124204B (da) Analogifremgangsmåde til fremstilling af derivater af 3-phenyl-2-oxo-4-thion- eller 3-phenyl-2,4-dithion-dihydrobenzoxaziner-(1,3).